The FDA is correct in that the endpoints failed. O
Post# of 148268
(Total Views: 584)
Posted On: 05/17/2021 3:46:11 PM
Re: craigakess #90451
The FDA is correct in that the endpoints failed. Of course no explanation by the FDA of why the endpoints failed including the FDA not allowing us 4 doses in the severe/critical trial. We know leronlimab is showing clinical benefit and the FDA will be backpedaling after the Brazil trials.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼